Free Trial
NYSE:CLVT

Clarivate Q2 2025 Earnings Report

Clarivate logo
$4.50 +0.10 (+2.27%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$4.54 +0.04 (+0.78%)
As of 07/8/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clarivate EPS Results

Actual EPS
N/A
Consensus EPS
$0.18
Beat/Miss
N/A
One Year Ago EPS
N/A

Clarivate Revenue Results

Actual Revenue
N/A
Expected Revenue
$587.17 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Clarivate Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, July 30, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Clarivate Earnings Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Clarivate Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Clarivate? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clarivate and other key companies, straight to your email.

About Clarivate

Clarivate (NYSE:CLVT) is a global information services and analytics company that provides trusted insights and workflow solutions for researchers, innovators and intellectual property professionals. Its offerings span scientific and academic research, patent intelligence, regulatory and competitive intelligence, trademark protection and domain management. By combining proprietary data sources with advanced analytics and AI-driven algorithms, Clarivate enables organizations to accelerate innovation, protect and maximize the value of their intellectual assets, and make better-informed decisions across the research and development lifecycle.

The company’s flagship products include Web of Science, a citation indexing and discovery platform widely used by academic and corporate researchers; Cortellis, which delivers drug discovery and development intelligence for life sciences and pharmaceutical companies; and Derwent World Patents Index, a comprehensive database of global patent information. Clarivate also offers trademark research and brand protection solutions through CompuMark and MarkMonitor, along with scholar manuscript submission and peer review management via ScholarOne. These integrated tools support customers in universities, government agencies, multinational corporations and professional services firms around the world.

Clarivate was established in 2016 following a spin-off from Thomson Reuters’ Intellectual Property & Science business and later went public on the New York Stock Exchange under the ticker CLVT. Its heritage traces back several decades of data aggregation and analytics, reflecting a long-standing commitment to accuracy, transparency and innovation. Over time, the company has expanded its coverage and capabilities through strategic acquisitions and continued investment in artificial intelligence, machine learning and cloud-based platforms.

Headquartered in London, Clarivate serves more than 50,000 customers across over 100 countries, with regional offices in North America, Europe and the Asia-Pacific region. Under the leadership of Executive Chair and Chief Executive Officer Jerre Stead and a seasoned management team, Clarivate continues to broaden its product portfolio, enhance its technological infrastructure and deepen customer partnerships to support the evolving needs of researchers, IP professionals and business leaders worldwide.

View Clarivate Profile

More Earnings Resources from MarketBeat